Dear Global Health Community, I hope this week’s news selection finds you well. Read below:
Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord (Health Policy Watch, April 14, 2023)
> CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. https://healthpolicy-watch.news/pharmaceutical-ceos-to-g7-protect-intel…
China records world's first human death from H3N8 bird flu, WHO says (Reuters, April 12, 2023)
> A Chinese woman has become the first person to die from a type of bird flu that is rare in humans, the World Health Organisation (WHO) said, but the strain does not appear to spread between people. https://www.reuters.com/world/china/china-records-worlds-first-human-de…
Flexibly funding WHO? An analysis of its donors’ voluntary contributions (BMJ, April 6, 2023)
> A recent article argues that the WHO needs to explore new incentives for flexible donations. https://gh.bmj.com/content/8/4/e011232
DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment (Health Policy Watch, April 13, 2023)
> When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. https://healthpolicy-watch.news/dndi-offers-model-for-pandemic-accord-n…